A Survey of Patient Experience in CML: American and Canadian Perspectives

Author:

Hillis Christopher,Flynn Kathryn E,Goldman Erinn Hoag,Moreira-Lucas Tracy SORCID,Visentini Josie,Dorman Stephanie,Ballinger Rachel,Byrnes Hilary FORCID,De Palma Andrea,Barbier ValentinORCID,Machado Lisa,Atallah Ehab

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference44 articles.

1. Needs for information and reasons for (non)adherence in chronic myeloid leukaemia: Be aware of social activities disturbing daily routines

2. Chronic Myeloid Leukemia in 2007

3. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

4. New Anticancer Drugs Associated With Large Increases In Costs And Life Expectancy

5. Canadian_Cancer_Society. Survival statistics for chronic myelogenous leukemia; 2022. Available from: https://cancer.ca/en/cancer-information/cancer-types/chronic-myelogenous-leukemia-cml/prognosis-and-survival/survival-statistics. Accessed January 26, 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3